Cargando…
Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437335/ https://www.ncbi.nlm.nih.gov/pubmed/36060948 http://dx.doi.org/10.3389/fendo.2022.963467 |
_version_ | 1784781583552610304 |
---|---|
author | Erazmus, Michał Rumińska, Małgorzata Witkowska-Sędek, Ewelina Kucharska, Anna M. Stelmaszczyk-Emmel, Anna Majcher, Anna Pyrżak, Beata |
author_facet | Erazmus, Michał Rumińska, Małgorzata Witkowska-Sędek, Ewelina Kucharska, Anna M. Stelmaszczyk-Emmel, Anna Majcher, Anna Pyrżak, Beata |
author_sort | Erazmus, Michał |
collection | PubMed |
description | INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. MATERIAL AND METHODS: The study included 70 children with overweight and obesity (mean age 13.0 ± 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. RESULTS: Overweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (β = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. CONCLUSION: Excess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies. |
format | Online Article Text |
id | pubmed-9437335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94373352022-09-03 Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children Erazmus, Michał Rumińska, Małgorzata Witkowska-Sędek, Ewelina Kucharska, Anna M. Stelmaszczyk-Emmel, Anna Majcher, Anna Pyrżak, Beata Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. MATERIAL AND METHODS: The study included 70 children with overweight and obesity (mean age 13.0 ± 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. RESULTS: Overweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (β = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. CONCLUSION: Excess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies. Frontiers Media S.A. 2022-08-19 /pmc/articles/PMC9437335/ /pubmed/36060948 http://dx.doi.org/10.3389/fendo.2022.963467 Text en Copyright © 2022 Erazmus, Rumińska, Witkowska-Sędek, Kucharska, Stelmaszczyk-Emmel, Majcher and Pyrżak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Erazmus, Michał Rumińska, Małgorzata Witkowska-Sędek, Ewelina Kucharska, Anna M. Stelmaszczyk-Emmel, Anna Majcher, Anna Pyrżak, Beata Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title | Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title_full | Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title_fullStr | Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title_full_unstemmed | Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title_short | Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children |
title_sort | decreased level of soluble receptor activator of nuclear factor-κβ ligand (srankl) in overweight and obese children |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437335/ https://www.ncbi.nlm.nih.gov/pubmed/36060948 http://dx.doi.org/10.3389/fendo.2022.963467 |
work_keys_str_mv | AT erazmusmichał decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT ruminskamałgorzata decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT witkowskasedekewelina decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT kucharskaannam decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT stelmaszczykemmelanna decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT majcheranna decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren AT pyrzakbeata decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren |